Efficacy and tolerability of two different formulations of atorvastatin in Korean patients with hypercholesterolemia: a multicenter, prospective, randomized clinical trial

PURPOSE: This study was designed to compare the efficacy and tolerability of the generic formulation (Atorva(®)) and the reference formulation (Lipitor(®)) of atorvastatin, both at a dosage of 20 mg once daily. METHODS: This study was a prospective open-label, randomized controlled study. Hyperchole...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ju-Hee, Kim, Sang-Hyun, Choi, Dong-Ju, Tahk, Seung-Jea, Yoon, Jung-Han, Choi, Si Wan, Hong, Taek-Jong, Kim, Hyo-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546732/
https://www.ncbi.nlm.nih.gov/pubmed/28814835
http://dx.doi.org/10.2147/DDDT.S112241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546732/
https://www.ncbi.nlm.nih.gov/pubmed/28814835
http://dx.doi.org/10.2147/DDDT.S112241

Ejemplares similares